{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:43:10Z","timestamp":1790311390677,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["94213"],"award-info":[{"award-number":["94213"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","bloodreviews.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.blre.2016.05.002","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T01:07:00Z","timestamp":1463792820000},"page":"421-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels"],"prefix":"10.1016","volume":"30","author":[{"given":"Sunelle A.","family":"Barnard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlien","family":"Pieters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelda","family":"De Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.blre.2016.05.002_bb0005","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1056\/NEJM200006153422406","article-title":"Plasminogen-activator inhibitor type 1 and coronary artery disease","volume":"342","author":"Kohler","year":"2000","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0010","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5539\/jfr.v3n6p36","article-title":"The role of plasminogen activator inhibitor-1 in the metabolic syndrome and its regulation","volume":"3","author":"Phelan","year":"2014","journal-title":"J Food Res"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1160\/TH07-11-0682","article-title":"Metabolic syndrome, haemostasis and thrombosis","volume":"99","author":"Alessi","year":"2008","journal-title":"Thromb Haemost"},{"issue":"8","key":"10.1016\/j.blre.2016.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.ijo.0803189","article-title":"Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome","volume":"30","author":"Mertens","year":"2006","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0025","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2337\/diab.46.5.860","article-title":"Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease","volume":"46","author":"Alessi","year":"1997","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0030","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s001250050868","article-title":"Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals","volume":"41","author":"Eriksson","year":"1998","journal-title":"Diabetologia"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0035","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/BF03401641","article-title":"Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice","volume":"2","author":"Samad","year":"1996","journal-title":"Mol Med"},{"issue":"7","key":"10.1016\/j.blre.2016.05.002_bb0040","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","article-title":"Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity","volume":"2","author":"Shimomura","year":"1996","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0045","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1160\/TH11-11-0822","article-title":"Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue","volume":"108","author":"Ekstr\u00f6m","year":"2012","journal-title":"Thromb Haemost"},{"issue":"7","key":"10.1016\/j.blre.2016.05.002_bb0050","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1161\/01.ATV.0000077401.36885.BB","article-title":"Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation","volume":"23","author":"Alessi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0055","first-page":"1161","article-title":"Role of the 4G\/5G polymorphism of PAI-1 gene promoter on PAI-1 levels in obese patients: influence of fat distribution and insulin-resistance","volume":"86","author":"Sartori","year":"2001","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0060","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1161\/hq0102.101552","article-title":"Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits","volume":"22","author":"Bastelica","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0065","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0026-0495(00)80046-3","article-title":"Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture","volume":"49","author":"Gottschling-Zeller","year":"2000","journal-title":"Metabolism"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0070","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","article-title":"Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1","volume":"28","author":"Skurk","year":"2004","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.blre.2016.05.002_bb0075","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pnmrs.2013.04.001","article-title":"Whole body fat: content and distribution","volume":"73","author":"Thomas","year":"2013","journal-title":"Prog Nucl Mag Res Sp"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1160\/TH13-04-0285","article-title":"Ectopic fat: the true culprit linking obesity and cardiovascular disease?","volume":"110","author":"Morelli","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.blre.2016.05.002_bb0085","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1038\/sj.ijo.0802853","article-title":"Failure of fat cell proliferation, mitochondrial function and fat oxidation results in ectopic fat storage, insulin resistance and type II diabetes mellitus","volume":"28","author":"Heilbronn","year":"2004","journal-title":"Int J Obes (Lond)"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0090","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cmet.2008.04.004","article-title":"Beneficial effects of subcutaneous fat transplantation on metabolism","volume":"7","author":"Tran","year":"2008","journal-title":"Cell Metab"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0095","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/dc08-2280","article-title":"Abdominal subcutaneous adipose tissue: a protective fat depot?","volume":"32","author":"Porter","year":"2009","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0100","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2011-0615","article-title":"Preferential fat deposition in subcutaneous versus visceral depots is associated with insulin sensitivity","volume":"96","author":"McLaughlin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0105","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.2337\/db14-0385","article-title":"Distinct developmental profile of lower-body adipose tissue defines resistance against obesity-associated metabolic complications","volume":"63","author":"Pinnick","year":"2014","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0110","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0021-9150(98)00281-0","article-title":"Expression of plasminogen activator inhibitor-1 in human adipose tissue: a role for TNF-\u03b1?","volume":"143","author":"Cigolini","year":"1999","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0115","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/sj.ijo.0800585","article-title":"Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women","volume":"22","author":"Janand-Delenne","year":"1998","journal-title":"Int J Obes (Lond)"},{"issue":"11\u201312","key":"10.1016\/j.blre.2016.05.002_bb0120","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1055\/s-2007-978677","article-title":"Fat cell function and fibrinolysis","volume":"32","author":"Alessi","year":"2000","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0125","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1055\/s-0037-1613860","article-title":"Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals","volume":"83","author":"Eriksson","year":"2000","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0130","first-page":"356","article-title":"Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin","volume":"36","author":"Declerck","year":"2013","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.blre.2016.05.002_bb0135","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.thromres.2016.02.002","article-title":"Plasminogen activator inhibitor and the risk of cardiovascular disease: the Framingham Heart Study","volume":"140","author":"Tofler","year":"2016","journal-title":"Thromb Res"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0140","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/01.ATV.19.5.1361","article-title":"PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level","volume":"19","author":"Morange","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0145","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s001250100007","article-title":"Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss","volume":"44","author":"Mavri","year":"2001","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0150","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/sj.ijo.0803650","article-title":"Human visceral adipose tissue and the plasminogen activator inhibitor type 1","volume":"31","author":"Lindeman","year":"2007","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-3848(99)00061-4","article-title":"Lack of evidence for secretion of plasminogen activator inhibitor-1 by human subcutaneous adipose tissue in vivo","volume":"96","author":"Yudkin","year":"1999","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0160","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-789X.2009.00623.x","article-title":"Subcutaneous and visceral adipose tissue: structural and functional differences","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Obes Rev"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0165","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1097\/01.ASN.0000141966.69934.21","article-title":"The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity","volume":"15","author":"Wisse","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0170","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1210\/jc.2004-1696","article-title":"Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT","volume":"90","author":"Bruun","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0175","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s00125-006-0173-z","article-title":"Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin","volume":"49","author":"Curat","year":"2006","journal-title":"Diabetologia"},{"issue":"10","key":"10.1016\/j.blre.2016.05.002_bb0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0753-3322(00)88103-2","article-title":"Plasma plasminogen activator inhibitor 1, insulin resistance and android obesity","volume":"53","author":"Bastard","year":"1999","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0185","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S0925-4439(99)00091-5","article-title":"Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues","volume":"1500","author":"Dusserre","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0190","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.ijo.0801087","article-title":"Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects","volume":"24","author":"Bastard","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0195","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0049-3848(01)00267-5","article-title":"Similar PAI-1 expression in visceral and subcutaneous fat of postmenopausal women","volume":"102","author":"Polac","year":"2001","journal-title":"Thromb Res"},{"issue":"8","key":"10.1016\/j.blre.2016.05.002_bb0200","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.ATV.14.8.1264","article-title":"Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity","volume":"14","author":"Mykkanen","year":"1994","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.blre.2016.05.002_bb0205","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/sj.ijo.0800435","article-title":"Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution","volume":"21","author":"De Pergola","year":"1997","journal-title":"Int J Obes (Lond)"},{"issue":"9","key":"10.1016\/j.blre.2016.05.002_bb0210","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/CS20070084","article-title":"Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women","volume":"113","author":"Peverill","year":"2007","journal-title":"Clin Sci"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0215","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.thromres.2015.05.033","article-title":"The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults","volume":"136","author":"Eksteen","year":"2015","journal-title":"Thromb Res"},{"issue":"7","key":"10.1016\/j.blre.2016.05.002_bb0220","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.numecd.2006.04.006","article-title":"Differences in the association of PAI-1 activity with the metabolic syndrome between African and Caucasian women","volume":"17","author":"Greyling","year":"2007","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0225","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/ajcn\/69.3.381","article-title":"Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study","volume":"69","author":"Hill","year":"1999","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.blre.2016.05.002_bb0230","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.2337\/diabetes.49.8.1374","article-title":"Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity","volume":"49","author":"Alessi","year":"2000","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0235","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1381\/096089202321019620","article-title":"Ultrasound measurement of visceral and subcutaneous fat in morbidly obese patients before and after laparoscopic adjustable gastric banding: comparison with computerized tomography and with anthropometric measurements","volume":"12","author":"Pontiroli","year":"2002","journal-title":"Obes Surg"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0240","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1161\/01.ATV.18.11.1716","article-title":"Visceral fat accumulation is an important determinant of PAI-1 levels in young, nonobese men and women: modulation by cross-sex hormone administration","volume":"18","author":"Giltay","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0245","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ajcn\/74.5.631","article-title":"Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss","volume":"74","author":"Weinsier","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0250","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/01.ATV.17.3.553","article-title":"Gender differences in the relationships between plasma plasminogen activator inhibitor-1 activity and factors linked to the insulin resistance syndrome in essential hypertension","volume":"17","author":"Toft","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0255","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/j.1550-8528.1996.tb00536.x","article-title":"The degree of masculine differentiation of obesities","volume":"4","author":"Vague","year":"1996","journal-title":"Obes Res"},{"issue":"11\u201312","key":"10.1016\/j.blre.2016.05.002_bb0260","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-2002-38256","article-title":"Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome","volume":"34","author":"Wajchenberg","year":"2002","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0265","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1055\/s-0037-1614860","article-title":"Relationship between visceral fat and PAI-1 in overweight men and women before and after weight loss","volume":"82","author":"Kockx","year":"1999","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0270","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.diabres.2007.08.030","article-title":"Expression of TNF-\u03b1 protein in omental and subcutaneous adipose tissue in obesity","volume":"79","author":"Cao","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"issue":"27","key":"10.1016\/j.blre.2016.05.002_bb0275","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.2174\/092986707782359972","article-title":"Estrogens and glucocorticoid hormones in adipose tissue metabolism","volume":"14","author":"Mattsson","year":"2007","journal-title":"Curr Med Chem"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0280","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1365-2796.2008.01999.x","article-title":"Low PAI-1 activity in relation to inflammatory parameters, insulin profile and body mass index","volume":"264","author":"\u00c5gren","year":"2008","journal-title":"J Intern Med"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0285","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/sj.ijo.0802192","article-title":"Insulin resistance but not visceral adipose tissue is associated with plasminogen activator inhibitor type 1 levels in overweight and obese premenopausal African-American women","volume":"27","author":"Solano","year":"2003","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0290","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ajcn\/61.4.765","article-title":"Visceral adipose tissue differences in black and white women","volume":"61","author":"Conway","year":"1995","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/oby.2010.201","article-title":"Waist circumference, BMI, and visceral adipose tissue in white women and women of African descent","volume":"19","author":"Sumner","year":"2011","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0300","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.metabol.2008.09.007","article-title":"The atypical presentation of the metabolic syndrome components in black African women: the relationship with insulin resistance and the influence of regional adipose tissue distribution","volume":"58","author":"Jennings","year":"2009","journal-title":"Metabolism"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0305","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/oby.2009.292","article-title":"Dual-energy X-ray absorptiometry and anthropometric estimates of visceral fat in black and white South African women","volume":"18","author":"Micklesfield","year":"2010","journal-title":"Obesity"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0310","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/oby.2011.361","article-title":"Alterations in the common pathway of coagulation during weight loss induced by gastric bypass in severely obese patients","volume":"20","author":"Pardina","year":"2012","journal-title":"Obesity"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0315","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1161\/01.ATV.13.2.162","article-title":"Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults","volume":"13","author":"Folsom","year":"1993","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0320","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ajcn\/64.1.7","article-title":"Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction","volume":"64","author":"Calles-Escandon","year":"1996","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0325","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/01.ATV.16.3.381","article-title":"Plasminogen activator inhibitor\u20131, tissue-type plasminogen activator, and fibrinogen effect of dieting with or without exercise in overweight postmenopausal women","volume":"16","author":"Svendsen","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0330","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.numecd.2010.07.009","article-title":"Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery","volume":"22","author":"Tschoner","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.blre.2016.05.002_bb0335","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0049-3848(01)00292-4","article-title":"Regulation of PAI-1 expression by genetic polymorphisms: impact on atherogenesis","volume":"103","author":"Nordt","year":"2001","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11886-999-0069-x","article-title":"Fibrinolytic function and coronary risk","volume":"1","author":"Juhan-Vague","year":"1999","journal-title":"Curr Cardiol Rep"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0345","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jped.2013.01.004","article-title":"Body adiposity but not insulin resistance is associated with-675 4G\/5G polymorphism in the PAI-1 gene in a sample of Mexican children","volume":"89","author":"De la Cruz-Mosso","year":"2013","journal-title":"J Pediatr (Rio J)"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0350","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00042192-200512020-00006","article-title":"Plasminogen-activator inhibitor-1 polymorphisms are associated with obesity and fat distribution in the Quebec Family Study: evidence of interactions with menopause","volume":"12","author":"Bouchard","year":"2005","journal-title":"Menopause"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0355","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1515\/JPEM.2006.19.5.741","article-title":"Plasminogen activator inhibitor-1 (PAI-1) gene polymorphism (-675 4G\/SG) associated with obesity and vascular risk in children","volume":"19","author":"Berbero\u01e7lu","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0360","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s00125-001-0774-5","article-title":"The common-675 4G\/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity","volume":"45","author":"Hoffstedt","year":"2002","journal-title":"Diabetologia"},{"issue":"15","key":"10.1016\/j.blre.2016.05.002_bb0365","doi-asserted-by":"crossref","first-page":"10739","DOI":"10.1016\/S0021-9258(18)82047-6","article-title":"The two allele sequences of a common polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene respond differently to interleukin-1 in HepG2 cells","volume":"268","author":"Dawson","year":"1993","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0370","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.blre.2016.05.002_bb0375","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1160\/TH03-08-0546","article-title":"Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk","volume":"91","author":"Hoekstra","year":"2004","journal-title":"Thromb Haemost"},{"issue":"1\u20132","key":"10.1016\/j.blre.2016.05.002_bb0380","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11010-012-1230-1","article-title":"4G\/5G polymorphism modulates PAI-1 circulating levels in obese women","volume":"364","author":"Fernandes","year":"2012","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0385","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2005.01.036","article-title":"The plasminogen activator inhibitor-1 (PAI-1) promoter haplotype is related to PAI-1 plasma concentrations in lean individuals","volume":"181","author":"Verschuur","year":"2005","journal-title":"Atherosclerosis"},{"issue":"12","key":"10.1016\/j.blre.2016.05.002_bb0390","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1007\/s001250050606","article-title":"Promoter (4G\/5G) plasminogen activator inhibitor-1 genotype in Pima Indians: relationship to plasminogen activator inhibitor-1 levels and features of the insulin resistance syndrome","volume":"39","author":"McCormack","year":"1996","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.blre.2016.05.002_bb0395","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/01.ATV.17.1.33","article-title":"Plasminogen activator inhibitor-1 promoter 4G\/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography","volume":"17","author":"Ossei-Gerning","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0400","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000079243","article-title":"Association analysis of the plasminogen activator inhibitor-1 4G\/5G polymorphism in Hispanics and African Americans: the IRAS family study","volume":"57","author":"Bensen","year":"2004","journal-title":"Hum Hered"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0405","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00125-002-0961-z","article-title":"To: J. Hoffstedt et al. (2002). The common\u2013675 4G\/5G polymorphism in the plasminogen activator inhibitor-1 gene is strongly associated with obesity","volume":"45","author":"Freeman","year":"2002","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0410","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.thromres.2007.10.016","article-title":"Plasminogen activator inhibitor-1 levels in severe and morbid obesity. Effect of weight loss and influence of 4G\/5G polymorphism","volume":"122","author":"Sol\u00e1","year":"2008","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0415","first-page":"647","article-title":"Plasma PAI-1 levels in obese children\u2014effect of weight loss and influence of PAI-1 promoter 4G\/5G genotype","volume":"86","author":"Estell\u00e9s","year":"2001","journal-title":"Thromb Haemost"},{"issue":"12","key":"10.1016\/j.blre.2016.05.002_bb0420","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083151","article-title":"In black South Africans from rural and urban communities, the 4G\/5G PAI-1 polymorphism influences PAI-1 activity, but not plasma clot lysis time","volume":"8","author":"De Lange","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0425","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1177\/1076029607305081","article-title":"The effect of plasminogen activator inhibitor-1-675 4G\/5G polymorphism on PAI-1 gene expression and adipocyte differentiation","volume":"14","author":"Ozel Demiralp","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0430","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1055\/s-0037-1613803","article-title":"Role of gender and genetic variance in plasminogen activator inhibitor-1 secretion from human adipose tissue","volume":"83","author":"Van Harmelen","year":"2000","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0435","doi-asserted-by":"crossref","first-page":"e301-e4","DOI":"10.1016\/j.thromres.2012.08.297","article-title":"Associations between plasma PAI-1 concentrations and its expressions in various organs in obese model mice","volume":"130","author":"Ohkura","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.blre.2016.05.002_bb0440","doi-asserted-by":"crossref","first-page":"513948","DOI":"10.1155\/2010\/513948","article-title":"Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review","volume":"2010","author":"Fain","year":"2010","journal-title":"Mediators Inflamm"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0445","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coph.2005.01.007","article-title":"Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease","volume":"5","author":"De Taeye","year":"2005","journal-title":"Curr Opin Pharmacol"},{"issue":"3\u20134","key":"10.1016\/j.blre.2016.05.002_bb0450","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1159\/000093221","article-title":"Effects of VLDL and remnant particles on platelets","volume":"35","author":"Olufadi","year":"2006","journal-title":"Pathophysiol Haemost Thromb"},{"issue":"11","key":"10.1016\/j.blre.2016.05.002_bb0455","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.ATV.18.11.1679","article-title":"Unsaturated fatty acids increase plasminogen activator inhibitor-1 expression in endothelial cells","volume":"18","author":"Nilsson","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.blre.2016.05.002_bb0460","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0895-7061(01)02191-4","article-title":"Effect of obesity on endothelium-dependent, nitric oxide\u2013mediated vasodilation in normotensive individuals and patients with essential hypertension","volume":"14","author":"Higashi","year":"2001","journal-title":"Am J Hypertens"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0465","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1476-5381.2011.01661.x","article-title":"Human obesity and endothelium-dependent responsiveness","volume":"165","author":"Campia","year":"2012","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.blre.2016.05.002_bb0470","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/dmrr.1183","article-title":"Contributions of dysglycaemia, obesity, and insulin resistance to impaired endothelium-dependent vasodilation in humans","volume":"27","author":"Han","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"issue":"10","key":"10.1016\/j.blre.2016.05.002_bb0475","first-page":"3527","article-title":"Endothelial cells in physiology and in the pathophysiology of vascular disorders","volume":"91","author":"Cines","year":"1998","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0480","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1515\/hmbci-2015-0039","article-title":"The study of markers of endothelial dysfunction in metabolic syndrome","volume":"24","author":"Ahirwar","year":"2015","journal-title":"Horm Mol Biol Clin Investig"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0485","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1046\/j.1365-2796.1999.00490.x","article-title":"The role of TNF\u03b1 and TNF receptors in obesity and insulin resistance","volume":"245","author":"Hotamisligil","year":"1999","journal-title":"J Intern Med"},{"issue":"12","key":"10.1016\/j.blre.2016.05.002_bb0490","doi-asserted-by":"crossref","first-page":"6902","DOI":"10.1073\/pnas.96.12.6902","article-title":"Tumor necrosis factor \u03b1 is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1","volume":"96","author":"Samad","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.blre.2016.05.002_bb0495","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1161\/01.ATV.20.6.1682","article-title":"Role of cytokines in the regulation of plasminogen activator inhibitor-1 expression and secretion in newly differentiated subcutaneous human adipocytes","volume":"20","author":"Birgel","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0500","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0002-9440(10)63888-6","article-title":"Divergent roles for p55 and p75 TNF-\u03b1 receptors in the induction of plasminogen activator inhibitor-1","volume":"162","author":"Pandey","year":"2003","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.blre.2016.05.002_bb0505","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1182\/blood.V69.2.381.381","article-title":"Plasminogen activator inhibitors","volume":"69","author":"Sprengers","year":"1987","journal-title":"Blood"},{"issue":"03","key":"10.1016\/j.blre.2016.05.002_bb0510","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1079\/PNS200199","article-title":"Plasminogen activator inhibitor-1 and haemostasis in obesity","volume":"60","author":"Mutch","year":"2001","journal-title":"Proc Nutr Soc"},{"issue":"3","key":"10.1016\/j.blre.2016.05.002_bb0515","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/MOL.0b013e32814e6d29","article-title":"Plasminogen activator inhibitor-1, adipose tissue and insulin resistance","volume":"18","author":"Alessi","year":"2007","journal-title":"Curr Opin Lipidol"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X16300200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T19:03:10Z","timestamp":1718564590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X16300200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0268960X16300200"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2016.05.002","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2016.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}